- Advanced search
|International Nonproprietary Names|
|47H4 v5 hulgG1||2|
|Search PubMed clinical trials||quilizumab|
|Search PubMed titles||quilizumab|
|Search PubMed titles/abstracts||quilizumab|
|Quilizumab is a humanized IgG1κ investigational monoclonal antibody designed to bind the M1' segment of membrane-bound immunoglobulin E (mIgE), which is part of the B-cell receptor (BCR) on B cells .
Peptide sequences and 3D structural information for this antibody are available from its IMGT/mAb-DB record.
BLAST peptide analysis reveals 100% matches with sequences claimed in patent US8071097 B2 .